Latest stories on ESPR
Esperion Shareholders Approve Directors, Pay, and Equity Plan
TipRanks50 · neutralgeneral
Epilogue On Esperion Therapeutics (Rating Downgrade)
Seeking Alpha33 · bearishanalyst
ESPR news roundup. 1 story in the past week, 3 over 30 days. Average 30-day sentiment is 47/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.